AGR2 and cancer: It has already been described for various cancer progression-associated factors such as AGR2, SIP1 and YB1 [28–30] to promote on the one hand tumor cell migration while inhibiting tumor growth on the other hand as demonstrated for NMU in our SKBR3 in vitro model.